The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $44.24

Today's change-0.61 -1.36%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $44.24

Today's change-0.61 -1.36%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Cambrex Corp down (U.S.)$0.61

Cambrex Corp closed lower Thursday, dropping (U.S.)$0.61 or 1.36% to (U.S.)$44.24. Over the last five days, shares have gained 0.57% and are currently 4.96% off of the 52-week high. Shares have outperformed the S&P 500 by 97.58% during the last year.

Key company metrics

  • Open(U.S.) $44.70
  • Previous close(U.S.) $44.85
  • High(U.S.) $45.08
  • Low(U.S.) $43.44
  • Bid / Ask-- / --
  • YTD % change+104.63%
  • Volume255,071
  • Average volume (10-day)320,384
  • Average volume (1-month)345,941
  • Average volume (3-month)425,489
  • 52-week range(U.S.) $15.76 to (U.S.) $46.55
  • Beta0.76
  • Trailing P/E21.56×
  • P/E 1 year forward25.72×
  • Forward PEG1.71×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.05
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.92%

Based on its net profit margin of 16.92%, Cambrex Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.30%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue781298198
Total other revenue--------
Total revenue781298198
Gross profit29452833
Total cost of revenue48845364
Total operating expense651076983
Selling / general / administrative14141315
Research & development3344
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--600
Other operating expenses, total--------
Operating income13231215
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12221110
Income after tax828920
Income tax, total4-63-9
Net income828920
Total adjustments to net income--------
Net income before extra. items828920
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items828920
Inc. avail. to common incl. extra. items828920
Diluted net income828920
Dilution adjustment--------
Diluted weighted average shares32323231
Diluted EPS excluding extraordinary itemsvalue per share0.260.880.280.63
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.261.000.280.63